We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Buys

Rank Stock Value
1
COLD icon
Americold
COLD
+$166M
2
OHI icon
Omega Healthcare
OHI
+$102M
3
SUI icon
Sun Communities
SUI
+$98.2M
4
AIRC
Apartment Income REIT Corp.
AIRC
+$97.3M
5
DOC icon
Healthpeak Properties
DOC
+$93.5M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENE icon
1201
Xenon Pharmaceuticals
XENE
$6.25B
$1K ﹤0.01%
+66
New +$772
XERS icon
1202
Xeris Biopharma Holdings
XERS
$1.44B
$1K ﹤0.01%
102
-68
-40% -$340
ZG icon
1203
PUT
Zillow
ZG
$7.69B
$1K ﹤0.01%
1,688
– –
QTTB icon
1204
Q32 Bio
QTTB
$442M
$1K ﹤0.01%
6
-8
-57% -$1.55K
TECX
1205
Tectonic Therapeutic
TECX
$548M
$1K ﹤0.01%
7
-10
-59% -$1.78K
SYRS
1206
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1K ﹤0.01%
10
-17
-63% -$1.55K
PSTX
1207
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1K ﹤0.01%
+116
New +$1.22K
EGRX
1208
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30
-52
-63% -$2.43K
GTHX
1209
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1K ﹤0.01%
72
-140
-66% -$2.09K
FUSN
1210
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1K ﹤0.01%
+78
New +$980
MRNS
1211
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
+58
New +$809
EIGR
1212
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1K ﹤0.01%
2
-2
-50% -$574
GMDA
1213
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$1K ﹤0.01%
+93
New +$629
CBAY
1214
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
152
-226
-60% -$1.71K
BCEL
1215
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1K ﹤0.01%
65
-59
-48% -$885
ORTX
1216
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1K ﹤0.01%
13
-18
-58% -$806
RVLP
1217
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1K ﹤0.01%
140
-153
-52% -$882
PRTK
1218
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1K ﹤0.01%
+86
New +$506
SURF
1219
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
+77
New +$669
HARP
1220
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
+5
New +$773
KDNY
1221
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
+79
New +$1.19K
SPPI
1222
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1K ﹤0.01%
321
-317
-50% -$1.3K
ISEE
1223
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1K ﹤0.01%
+168
New +$1.07K
JNCE
1224
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1K ﹤0.01%
+75
New +$584
CNCE
1225
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1K ﹤0.01%
+58
New +$661
47 48
49
50 51

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.